HC Wainwright & Co. Reiterates Buy on Applied DNA Sciences, Maintains $5 Price Target
HC Wainwright & Co. analyst Yi Chen reiterates Applied DNA Sciences (NASDAQ:APDN) with a Buy and maintains $5 price target.
HC Wainwright & Co. Reiterates Buy on Sensus Healthcare, Maintains $16 Price Target
HC Wainwright & Co. analyst Yi Chen reiterates Sensus Healthcare (NASDAQ:SRTS) with a Buy and maintains $16 price target.
Mizuho Reiterates Buy on WEX, Maintains $200 Price Target
Mizuho analyst Dan Dolev reiterates WEX (NYSE:WEX) with a Buy and maintains $200 price target.
Mizuho Reiterates Buy on PayPal Holdings, Maintains $100 Price Target
Mizuho analyst Dan Dolev reiterates PayPal Holdings (NASDAQ:PYPL) with a Buy and maintains $100 price target.
HC Wainwright & Co. Reiterates Buy on Nuvectis Pharma, Maintains $21 Price Target
HC Wainwright & Co. analyst Joseph Pantginis reiterates Nuvectis Pharma (NASDAQ:NVCT) with a Buy and maintains $21 price target.
Needham Reiterates Buy on Coursera, Maintains $19 Price Target
Needham analyst Ryan MacDonald reiterates Coursera (NYSE:COUR) with a Buy and maintains $19 price target.
HC Wainwright & Co. Reiterates Buy on Orion Energy Sys, Maintains $7 Price Target
HC Wainwright & Co. analyst Amit Dayal reiterates Orion Energy Sys (NASDAQ:OESX) with a Buy and maintains $7 price target.
Needham Reiterates Buy on Engagesmart, Maintains $40 Price Target
Needham analyst Scott Berg reiterates Engagesmart (NYSE:ESMT) with a Buy and maintains $40 price target.
Needham Reiterates Buy on Intra-Cellular Therapies, Maintains $70 Price Target
Needham analyst Ami Fadia reiterates Intra-Cellular Therapies (NASDAQ:ITCI) with a Buy and maintains $70 price target.
Needham Reiterates Buy on Genpact, Maintains $56 Price Target
Needham analyst Mayank Tandon reiterates Genpact (NYSE:G) with a Buy and maintains $56 price target.